Eli Lilly Corp. buy Barclays PLC
Start price
23.01.24
/
50%
€580.50
Target price
23.01.25
€625.12
Performance (%)
25.75%
End price
24.01.25
€730.00
Summary
This prediction ended on 24.01.25 with a price of €730.00. The prediction had a final performance of 25.75%. A total of €4.82 was paid as dividends for this prediction. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | 0.922% | 0.922% | 16.410% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Barclays_PLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Barclays PLC from $630.00 to $680.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barclays_PLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€771.40
31.10.24
31.10.24
€896.61
31.10.25
31.10.25
-3.29%
01.11.25
01.11.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€859.00
11.07.24
11.07.24
€941.16
11.07.25
11.07.25
-21.42%
12.07.25
12.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€676.00
07.02.24
07.02.24
€751.76
07.02.25
07.02.25
26.20%
08.02.25
08.02.25